I Need Help

We're dedicated to helping you achieve your dream - having a baby. We offer a range of services - from IVF to genetic diagnosis of pre-implantation embryos - all with the aim of easing your journey to successful pregnancy.

I Need Help

We're dedicated to helping you achieve your dream - having a baby. We offer a range of services - from IVF to genetic diagnosis of pre-implantation embryos - all with the aim of easing your journey to successful pregnancy.

GeneSure - PGD / PGS

Genea’s full in-house GeneSure™ technology offers a faster way to a baby. And it’s more affordable than you think.

We all want a healthy baby, one who grows into a healthy child. Unfortunately, in some cases it’s not always how things turn out. Certain genetic conditions can cause birth defects or start to show up as a child develops and certain factors, such as knowing you have a family history of a genetic disease or being of advanced maternal age, can also increase the likelihood of your baby being affected. Genea’s world leading GeneSure Preimplantation Genetic Diagnosis (PGD) and Preimplantation Genetic Screening (PGS) is a way of reducing or removing that risk.

Can we benefit from Genea’s GeneSure?

This is recommended for you if you:

or your partner are affected by or carry a known genetic disease

If you know you carry a serious genetic condition, genetic testing of your embryos before implantation is an effective and logical way to avoid passing that condition onto your future children.

For example, when two cystic fibrosis carriers conceive a child, there is a 25 per cent chance that the baby will have cystic fibrosis, a 50 per cent chance that the baby will be a carrier and a 25 per cent chance that the baby will be unaffected. IVF with PGD allows the couple to produce a number of embryos, but to transfer only those that are either unaffected by the condition or carriers.

Genea has developed the largest range of tests in Australia - for more than 200 inherited diseases. Custom tests are designed just for you and can be developed for any single gene disorder.

are of advanced maternal age

Typically, as a woman’s age increases, selecting a healthy embryo becomes more of a challenge using the IVF technique alone as an embryo’s appearance doesn’t always tell the whole story.

It’s an unfortunate fact of reproductive science that the frequency of chromosomal abnormalities - that’s when your embryo is missing a chromosome or carrying an extra one - increases with maternal age. These chromosomal abnormalities can cause your embryo to fail to implant or miscarry or they might result in a baby born with developmental problems or a serious condition such as Down syndrome.

Our scientists use a form of PGS called Next Generation Sequencing (NGS) to screen your embryos in order to find those that have a balanced chromosome set. The good news is that our PGS results show that following the transfer of a tested embryo, pregnancy rates among older women do not differ greatly to those achieved by women in younger age groups.

have had recurrent miscarriages

Random chromosome problems are thought to be the cause of the majority of miscarriages - approximately seven out of 10 first trimester losses are caused by chromosome problems. What happens is that a genetically abnormal embryo implants in the uterus, but is destined to fail. Unfortunately miscarriages are not uncommon with approximately one in five pregnancies ending in a miscarriage. However, due to advanced maternal age or a number of other possible factors, some women are more prone to miscarriage. If you’ve experienced multiple miscarriages, considering PGS as part of your treatment may be the best way to achieve your goal and GeneSure may be an option for you.

Our scientists use Next Generation Sequencing (NGS) to screen your embryos to discover which ones have the correct number and sequence of chromosomes, to avoid the genetic faults that could be causing them to miscarry. We then only go on to transfer genetically healthy embryos.

have had a number of failed embryo transfers

Perhaps the problem you’re facing is that your IVF cycles are not working because your embryo fails to implant after the transfer. If this has happened a couple of times, your Fertility Specialist may recommend GeneSure.

A DNA sequence based method (Next Generation Sequencing or NGS) is used by our scientists to screen your embryo to ensure it has the correct number of chromosomes and to avoid some of the genetic faults that could be causing it to miscarry. We then only go on to transfer balanced embryos.

want to prevent the transmission of a sex-linked genetic disease

Using PGD to select the sex of your embryo is only allowed in Australia if the testing is being used to avoid passing on a specific sex-linked genetic disorder to a child.

If you’re having IVF because of changes in the male partner’s sperm analysis or Fallopian tube obstruction on the woman’s side, it’s likely that the female partner’s ovarian function may be very good and a high number of embryos may be produced in one IVF cycle.

In this instance, PGS can be used to screen those embryos to determine which ones are also chromosomally normal – leading to select the best embryo for transfer.

In Australia, Genea lead the way in investigating and developing PGD in Australia and our expertise and techniques are amongst the best in the world. They first launched chromosome testing of embryos in 1995 and expanded that treatment to offering single gene testing in 1998. You can learn more about Genea’s world leading PGD expertise on our PGD success rates page.

How does GeneSure enhance my IVF cycle?

In a standard IVF treatment, every time a cycle produces more than one embryo, our Embryologists must make a choice about which embryo will be transferred. That choice is determined by the development and appearance of the embryos, usually over a five day period.

With Genea’s GeneSure technology, our scientists analyse your embryos using advanced scientific techniques to assess their genetic make-up and therefore rule out embryos that contain an obvious genetic abnormality. This assessment can involve either a count of the chromosomes in each embryo and/or a molecular examination for a particular gene or mutation, these factors ultimately decide the health and potential of a pregnancy and any resulting baby.

PGD/PGS with Genea’s GeneSure technology can maximise the potential of a genetically normal embryo being selected, implanting successfully, carrying and delivering a baby.

If you’re considering IVF, GeneSure could be an important part of the equation.

To ensure more people can access GeneSure - Australia’s most successful PGD technology - Genea is offering a unique pricing option. Testing through Genea’s exclusive genetic technology suite will start at $800 per embryo tested (as of January 2017).

GeneSure can maximise the potential of a genetically normal embryo being selected, implanting successfully, carrying and delivering a baby in a single cycle. If you would like more information please call and speak with one of our Fertility Advisors or discuss your options with your Fertility Specialist.